The effects of electroconvulsive therapy on melatonin

Lois Elaine Krahn, Eileen Gleber, Teresa A. Rummans, Thomas S. Pileggi, Darlene L. Lucas, Hongzhe Li

Research output: Contribution to journalArticle

7 Citations (Scopus)

Abstract

Although several studies have investigated the impact of various antidepressant medications on melatonin, there are no published reports addressing the effects of electroconvulsive therapy (ECT). Melatonin's major urinary metabolite, 6-sulfatoxymelatonin (6MT), was measured before and after an acute course of ECT. Fourteen subjects diagnosed with major depression who had failed prior pharmacologic therapy were enrolled. 6MT excretion was measured using an enzyme-linked immunosorbent assay test in 24 hour samples separated into daytime and nighttime components. Hamilton Rating Scale for Depression scores showed a significant improvement (p < 0.0001). Data analysis using the Wilcoxon signed rank test demonstrated a significant decrease in 24 hour 6MT post-ECT (p < 0.016) and daytime 6MT (p < 0.008). These results demonstrate an association between a therapeutic response to ECT and decrease in endogenous melatonin production.

Original languageEnglish (US)
Pages (from-to)391-398
Number of pages8
JournalJournal of ECT
Volume16
Issue number4
StatePublished - 2000

Fingerprint

Electroconvulsive Therapy
Melatonin
Depression
Nonparametric Statistics
Antidepressive Agents
Enzyme-Linked Immunosorbent Assay
Therapeutics

Keywords

  • 6-Sulfatoxymelatonin
  • Electroconvulsive therapy
  • Major depression
  • Melatonin

ASJC Scopus subject areas

  • Psychiatry and Mental health

Cite this

Krahn, L. E., Gleber, E., Rummans, T. A., Pileggi, T. S., Lucas, D. L., & Li, H. (2000). The effects of electroconvulsive therapy on melatonin. Journal of ECT, 16(4), 391-398.

The effects of electroconvulsive therapy on melatonin. / Krahn, Lois Elaine; Gleber, Eileen; Rummans, Teresa A.; Pileggi, Thomas S.; Lucas, Darlene L.; Li, Hongzhe.

In: Journal of ECT, Vol. 16, No. 4, 2000, p. 391-398.

Research output: Contribution to journalArticle

Krahn, LE, Gleber, E, Rummans, TA, Pileggi, TS, Lucas, DL & Li, H 2000, 'The effects of electroconvulsive therapy on melatonin', Journal of ECT, vol. 16, no. 4, pp. 391-398.
Krahn LE, Gleber E, Rummans TA, Pileggi TS, Lucas DL, Li H. The effects of electroconvulsive therapy on melatonin. Journal of ECT. 2000;16(4):391-398.
Krahn, Lois Elaine ; Gleber, Eileen ; Rummans, Teresa A. ; Pileggi, Thomas S. ; Lucas, Darlene L. ; Li, Hongzhe. / The effects of electroconvulsive therapy on melatonin. In: Journal of ECT. 2000 ; Vol. 16, No. 4. pp. 391-398.
@article{1ce9e11f82ee47aea718dc26fabbdb2e,
title = "The effects of electroconvulsive therapy on melatonin",
abstract = "Although several studies have investigated the impact of various antidepressant medications on melatonin, there are no published reports addressing the effects of electroconvulsive therapy (ECT). Melatonin's major urinary metabolite, 6-sulfatoxymelatonin (6MT), was measured before and after an acute course of ECT. Fourteen subjects diagnosed with major depression who had failed prior pharmacologic therapy were enrolled. 6MT excretion was measured using an enzyme-linked immunosorbent assay test in 24 hour samples separated into daytime and nighttime components. Hamilton Rating Scale for Depression scores showed a significant improvement (p < 0.0001). Data analysis using the Wilcoxon signed rank test demonstrated a significant decrease in 24 hour 6MT post-ECT (p < 0.016) and daytime 6MT (p < 0.008). These results demonstrate an association between a therapeutic response to ECT and decrease in endogenous melatonin production.",
keywords = "6-Sulfatoxymelatonin, Electroconvulsive therapy, Major depression, Melatonin",
author = "Krahn, {Lois Elaine} and Eileen Gleber and Rummans, {Teresa A.} and Pileggi, {Thomas S.} and Lucas, {Darlene L.} and Hongzhe Li",
year = "2000",
language = "English (US)",
volume = "16",
pages = "391--398",
journal = "Journal of ECT",
issn = "1095-0680",
publisher = "Lippincott Williams and Wilkins",
number = "4",

}

TY - JOUR

T1 - The effects of electroconvulsive therapy on melatonin

AU - Krahn, Lois Elaine

AU - Gleber, Eileen

AU - Rummans, Teresa A.

AU - Pileggi, Thomas S.

AU - Lucas, Darlene L.

AU - Li, Hongzhe

PY - 2000

Y1 - 2000

N2 - Although several studies have investigated the impact of various antidepressant medications on melatonin, there are no published reports addressing the effects of electroconvulsive therapy (ECT). Melatonin's major urinary metabolite, 6-sulfatoxymelatonin (6MT), was measured before and after an acute course of ECT. Fourteen subjects diagnosed with major depression who had failed prior pharmacologic therapy were enrolled. 6MT excretion was measured using an enzyme-linked immunosorbent assay test in 24 hour samples separated into daytime and nighttime components. Hamilton Rating Scale for Depression scores showed a significant improvement (p < 0.0001). Data analysis using the Wilcoxon signed rank test demonstrated a significant decrease in 24 hour 6MT post-ECT (p < 0.016) and daytime 6MT (p < 0.008). These results demonstrate an association between a therapeutic response to ECT and decrease in endogenous melatonin production.

AB - Although several studies have investigated the impact of various antidepressant medications on melatonin, there are no published reports addressing the effects of electroconvulsive therapy (ECT). Melatonin's major urinary metabolite, 6-sulfatoxymelatonin (6MT), was measured before and after an acute course of ECT. Fourteen subjects diagnosed with major depression who had failed prior pharmacologic therapy were enrolled. 6MT excretion was measured using an enzyme-linked immunosorbent assay test in 24 hour samples separated into daytime and nighttime components. Hamilton Rating Scale for Depression scores showed a significant improvement (p < 0.0001). Data analysis using the Wilcoxon signed rank test demonstrated a significant decrease in 24 hour 6MT post-ECT (p < 0.016) and daytime 6MT (p < 0.008). These results demonstrate an association between a therapeutic response to ECT and decrease in endogenous melatonin production.

KW - 6-Sulfatoxymelatonin

KW - Electroconvulsive therapy

KW - Major depression

KW - Melatonin

UR - http://www.scopus.com/inward/record.url?scp=0034574757&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0034574757&partnerID=8YFLogxK

M3 - Article

C2 - 11314877

AN - SCOPUS:0034574757

VL - 16

SP - 391

EP - 398

JO - Journal of ECT

JF - Journal of ECT

SN - 1095-0680

IS - 4

ER -